Fig. 1From: Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaTrial schema. Radiation therapy begins between visit 1 and visit 2. All patients will be seen during weekly treatment visits throughout radiation therapy. Radiation therapy ends between visit 2 and visit 3. Surgical resection occurs between visit 3 and visit 4Back to article page